UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 8, 2004
-----------------
I-TRAX, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 001-31584 23-3057155
--------------------- ------------------------ -----------------------
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification No.)
incorporation)
4 Hillman Drive, Suite 130
Chadds Ford, Pennsylvania 19317
-------------------------------------- -----------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (610) 459-2405
One Logan Square
130 N. 18th St., Suite 2615
Philadelphia, Pennsylvania 19103
-------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
Arthur "Abbie" Leibowitz, M.D. resigned from I-trax, Inc.'s Board of
Directors on December 8, 2004. Dr. Leibowitz resigned because I-trax and Health
Advocate, Inc. have a business relationship and, as a result of that
relationship, Dr. Leibowitz felt that his position as the Executive Vice
President and Chief Medical Officer of Health Advocate could result in conflicts
of interest in the future if he continues as a director of I-trax.
SIGNATURES
Pursuant to requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
I-TRAX, INC.
Date: December 13, 2004 By: /s/ Frank A. Martin
------------------------------------
Name: Frank A. Martin
Title: Chief Executive Officer
-2-